Gerresheimer's Q1 2026 Sees Modest Revenue Growth and Emphasis on Cash Flow

Gerresheimer AG's preliminary results for Q1 2026 report modest revenue growth and a sharpened focus on free cash flow. The company achieved a free cash flow improvement of over 100 million EUR compared to the previous year, primarily due to strategies like selective investment planning and strict cash management. Revenues for the quarter reached 524 million EUR, a slight increase from 519 million EUR in Q1 2025. However, adjusted EBITDA saw a decline to 66 million EUR from 81 million EUR, reflecting the impact of reduced earnings focus.

The divisions Containment & Delivery Systems and Primary Injectable Solutions drove revenue growth through strong demand for drug delivery devices and syringe systems. The Moulded Glass division faced challenges, reporting a decrease in revenue attributed to a furnace repair and decreased demand in key sectors.

The sale of business units Centor and Primary Packaging Plastics, expected to reduce debt and strengthen financials, signifies a strategic pivot towards more high-value offerings. Gerresheimer anticipates improved financials in the second half of the year, fueled by the on-going transformation and strategic focus on core areas.